Medtronic had 15 patents in robotics during Q1 2024. Medtronic Plc’s patents in Q1 2024 include a system for infusing substances into a target object at varying flow rates, a surgical guide for use with surgical robots, a spinal surgery training process for predicting outcomes, a uterine manipulator for robotic systems, and a surgical robotic system with advanced control features for precise movements during surgery. GlobalData’s report on Medtronic gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Medtronic grant share with robotics as a theme is 66% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Robotically-assisted drug delivery (Patent ID: US20240096472A1)
The patent filed by Medtronic Plc describes a system that includes a processor and memory storing instructions to infuse a substance into a target object via an infusion device at a first flow rate, set a second flow rate based on the withdrawal rate of the infusion device, and infuse the substance into the target object at the second flow rate. The system also involves calculating remaining capacity in the target object, determining withdrawal rates based on substance properties, adjusting withdrawal rates based on elapsed duration, and setting flow rates based on insertion depth and approach angle of the infusion device.
The claims in the patent outline the specific functionalities of the system, such as calculating remaining capacity in the target object, determining withdrawal rates based on substance properties, adjusting withdrawal rates based on elapsed duration, setting flow rates based on insertion depth and approach angle of the infusion device, and utilizing machine learning models to optimize infusion parameters. The patent also covers methods for infusing substances into target objects, including setting flow rates based on withdrawal rates, calculating remaining capacity, adjusting withdrawal rates based on elapsed duration, and utilizing image data and substance properties to optimize infusion processes. Additionally, the patent includes a system with infusion management circuitry that controls substance infusion into target objects via a robot device and infusion device, based on withdrawal rates and remaining capacity calculations.
To know more about GlobalData’s detailed insights on Medtronic, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
